APPLIED ENERGETICS, INC. - Quarter Report: 2007 March (Form 10-Q)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
10-Q
x Quarterly
Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For
the
quarterly period ended March 31, 2007
OR
o Transition
Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934
For
the
transition period from __________ to __________
Commission
File Number 001-14015
IONATRON,
INC.
(Exact
Name of Registrant as Specified in Its Charter)
Delaware
|
77-0262908
|
|
(State
or Other Jurisdiction of Incorporation or Organization)
|
(IRS
Employer Identification Number)
|
3716
East Columbia Street, Suite 120
|
|
|
Tucson,
Arizona
|
85714
|
|
(Address
of Principal Executive
Offices)
|
(Zip
Code)
|
Registrant’s
telephone number, including area code
|
(520)
628-7415
|
Indicate
by check mark whether the registrant: (1) has filed all reports required to
be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the
preceding 12 months (or for such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filing requirements
for
the past 90 days. Yes x No o
Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, an accelerated filer, or a non-accelerated filer. See
definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of
the Exchange Act. (Check one):
Large
Accelerated Filer o
Accelerated Filer x
Non-Accelerated Filer o
Indicate
by check mark whether the Registrant is a shell company (as defined in Rule
12b-2 of the Exchange Act)
Yes
o
No x
Indicate
the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest practicable date. As of May 7, 2007 there were
78,968,119 shares of the issuer's common stock, par value $.001 per share,
outstanding.
IONATRON,
INC.
March
31,
2007
PART
I -
|
FINANCIAL
INFORMATION
|
|||
Item
1-
|
Consolidated
Financial Statements
|
|||
Consolidated
Balance Sheets as of March 31, 2007 (Unaudited) and December
31, 2006
|
3
|
|||
Consolidated
Statements of Operations for the three months ended March 31, 2007
and
2006 (Unaudited)
|
4
|
|||
Consolidated
Statements of Cash Flows for the three months ended March 31, 2007
and
2006 (Unaudited)
|
5
|
|||
Notes to Consolidated Financial Statements |
6
|
|||
Item
2-
|
Management's
Discussion and Analysis of Financial Condition and Results of
Operations
|
11
|
||
Item
4-
|
Controls
and Procedures
|
14
|
||
PART
II -
|
OTHER
INFORMATION
|
|||
Item
1-
|
Legal
Proceedings
|
15
|
||
Item
6-
|
Exhibits
|
16
|
||
SIGNATURES
|
17
|
-2-
PART
I FINANCIAL INFORMATION
ITEM
1. CONSOLIDATED FINANCIAL STATEMENTS
IONATRON,
INC.
CONSOLIDATED
BALANCE SHEETS
March
31, 2007
|
December
31, 2006
|
||||||
(Unaudited)
|
(Audited)
|
||||||
ASSETS
|
|||||||
Current
assets
|
|||||||
Cash
and cash equivalents
|
$
|
18,971,812
|
$
|
22,123,792
|
|||
Accounts
receivable - net
|
2,509,169
|
1,258,363
|
|||||
Inventory
|
2,948,727
|
2,214,471
|
|||||
Securities
available-for-sale
|
8,500,000
|
8,500,000
|
|||||
Prepaid
expenses and deposits
|
476,367
|
639,728
|
|||||
Other
receivables
|
1,279
|
2,918
|
|||||
Total
current assets
|
33,407,354
|
34,739,272
|
|||||
Property
and equipment - net
|
1,966,240
|
2,205,278
|
|||||
Other
assets
|
72,776
|
72,776
|
|||||
Intangible
assets - net
|
123,000
|
135,300
|
|||||
TOTAL
ASSETS
|
$
|
35,569,370
|
$
|
37,152,626
|
|||
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
|||||||
Current
liabilities
|
|||||||
Accounts
payable - net
|
$
|
794,992
|
$
|
570,572
|
|||
Accrued
expenses
|
277,386
|
638,925
|
|||||
Accrued
compensation
|
692,358
|
818,779
|
|||||
Customer
deposits
|
255,127
|
284,279
|
|||||
Current
portion of capital lease obligations
|
23,080
|
46,974
|
|||||
Total
current liabilities
|
2,042,943
|
2,359,529
|
|||||
Capital
lease obligations
|
10,438
|
30,536
|
|||||
Deferred
rent
|
121,074
|
112,641
|
|||||
Total
liabilities
|
2,174,455
|
2,502,706
|
|||||
Commitments
and contingencies
|
|||||||
Stockholders’
equity
|
|||||||
Series
A Convertible Preferred stock, $.001 par value, 2,000,000 shares
authorized
and 690,000 shares issued and outstanding at March 31, 2007 and
December 31, 2006.
|
690
|
690
|
|||||
Common
stock, $.001 par value, 100,000,000 shares authorized; 78,225,936
shares
issued and outstanding at March 31, 2007 and 78,171,267
shares issued
and outstanding at December 31, 2006
|
78,226
|
78,171
|
|||||
Additional
paid-in capital
|
61,886,666
|
60,488,633
|
|||||
Accumulated
deficit
|
(28,570,667
|
)
|
(25,917,574
|
)
|
|||
Total
stockholders’ equity
|
33,394,915
|
34,649,920
|
|||||
TOTAL
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
$
|
35,569,370
|
$
|
37,152,626
|
See
accompanying notes to consolidated financial statements (unaudited)
-3-
IONATRON,
INC.
CONSOLIDATED
STATEMENTS OF OPERATIONS
(Unaudited)
For
the three months ended
March
31,
|
|||||||
2007
|
2006
|
||||||
Revenue
|
$
|
2,070,610
|
$
|
5,074,827
|
|||
Cost
of revenue
|
2,337,994
|
4,767,178
|
|||||
Gross
profit (loss)
|
(267,384
|
)
|
307,649
|
||||
Operating
expenses:
|
|||||||
General
and administrative
|
2,219,622
|
2,621,496
|
|||||
Selling
and marketing
|
129,800
|
148,958
|
|||||
Research
and development
|
124,023
|
1,075,066
|
|||||
Total
operating expenses
|
2,473,445
|
3,845,520
|
|||||
Operating
loss
|
(2,740,829
|
)
|
(3,537,871
|
)
|
|||
Other
(expense) income
|
|||||||
Interest
expense
|
(999
|
)
|
(5,243
|
)
|
|||
Interest
income
|
383,826
|
112,120
|
|||||
Other
|
12
|
9
|
|||||
Total
other
|
382,839
|
106,886
|
|||||
Loss
before provision for income taxes
|
(2,357,990
|
)
|
(3,430,985
|
)
|
|||
Provision
for income taxes
|
-
|
11,299
|
|||||
Net
loss
|
(2,357,990
|
)
|
(3,442,284
|
)
|
|||
Preferred
stock dividends
|
(295,119
|
)
|
(303,660
|
)
|
|||
Net
loss attributable to common stockholders
|
$
|
(2,653,109
|
)
|
$
|
(3,745,944
|
)
|
|
Net
loss per common share – basic and diluted
|
$
|
(0.03
|
)
|
$
|
(0.05
|
)
|
|
Weighted
average number of shares outstanding, basic and diluted
|
78,171,872
|
72,174,683
|
See
accompanying notes to consolidated financial statements
(unaudited)
-4-
IONATRON,
INC.
CONSOLIDATED
STATEMENTS OF CASH FLOWS
(Unaudited)
For
the three months ended
March
31,
|
|||||||
2007
|
2006
|
||||||
CASH
FLOWS FROM OPERATING ACTIVITIES:
|
|||||||
Net
loss
|
$
|
(2,357,990
|
)
|
$
|
(3,442,284
|
)
|
|
Adjustments
to reconcile net loss to net cash used in operating
activities:
|
|||||||
Depreciation
and amortization
|
271,235
|
213,167
|
|||||
Loss
(gain) on equipment disposal
|
3,047
|
(25,041
|
)
|
||||
Deferred
income tax provision
|
-
|
10,200
|
|||||
Provision
for doubtful accounts
|
-
|
59,088
|
|||||
Provision
for losses on projects
|
248,000
|
139,996
|
|||||
Non-cash
stock based compensation expense
|
1,102,985
|
1,127,675
|
|||||
Changes
in assets and liabilities:
|
|||||||
Accounts
receivable
|
(1,250,806
|
)
|
(865,259
|
)
|
|||
Other
receivable
|
1,639
|
600
|
|||||
Inventory
|
(982,256
|
)
|
(1,550,306
|
)
|
|||
Prepaid
expenses and deposits
|
163,361
|
(245,738
|
)
|
||||
Accounts
payable
|
224,420
|
717,939
|
|||||
Billings
in excess of costs
|
-
|
(25,724
|
)
|
||||
Accrued
expenses, deposits and deferred rent
|
(508,679
|
)
|
685,115
|
||||
Net
cash used in operating activities
|
(3,085,044
|
)
|
(3,200,572
|
)
|
|||
CASH
FLOWS FROM INVESTING ACTIVITIES:
|
|||||||
Purchase
of equipment
|
(38,224
|
)
|
(336,907
|
)
|
|||
Proceeds
from sale of available-for-sale marketable securities
|
-
|
3,500,000
|
|||||
Purchases
of available-for-sale marketable securities
|
-
|
(500,000
|
)
|
||||
Proceeds
from disposal of equipment
|
15,280
|
-
|
|||||
Net
cash (used in) provided by investing activities
|
(22,944
|
)
|
2,663,093
|
||||
CASH
FLOWS FROM FINANCING ACTIVITIES:
|
|||||||
Principal
payments on capital lease obligations
|
(43,992
|
)
|
(9,148
|
)
|
|||
Exercise
of stock options and warrants
|
-
|
1,987,946
|
|||||
Net
cash (used in) provided by financing activities
|
(43,992
|
)
|
1,978,798
|
||||
Net
increase (decrease) in cash and cash equivalents
|
(3,151,980
|
)
|
1,441,319
|
||||
Cash
and cash equivalents, beginning of period
|
22,123,792
|
371,248
|
|||||
Cash
and cash equivalents, end of period
|
$
|
18,971,812
|
$
|
1,812,567
|
See
accompanying notes to consolidated financial statements
(unaudited)
-5-
1. NATURE
OF OPERATIONS AND BASIS OF PRESENTATION
NATURE
OF BUSINESS AND SUMMARY OF OPERATIONS:
Ionatron
was formed to develop and market Directed Energy Weapon products and other
products incorporating its proprietary Laser Induced Plasma Channel ("LIPC")
and
related technologies. Our goal is to deliver products that incorporate our
technology for sale to Government customers for specific applications and
platforms as well as products for other commercial customers. Ionatron has
entered into several contracts with the Government for products and services
as
well as Cooperative Research and Development Agreements for joint research
on
LIPC-based Directed Energy Weapons and Counter-Weapon Systems. We expect to
offer Government approved versions of our products for other Government and
non-Government security applications in the future. Since our inception, we
have
engaged in research and development and business development activities. Our
first Government contract was received in September of 2003. During 2004 we
demonstrated the laser guided man-made lightning Directed Energy technology
in
the laboratory, demonstrated the technology effects on a variety of targets
both
under Government contract and using internal research and development funding,
delivered a compact laser system specifically designed to enable the technology
under a Government contract; and commenced a Government contract for the
development of a system on a mobile platform for field demonstration and
testing. In 2005, utilizing contract and internal research and development
funds, we continued development of laser sources, advanced high voltage systems,
and special-purpose optical systems, expanded target effects testing under
Government contracts, and furthered our understanding of the underlying physics
of our systems and products. From the company’s inception to date, we have
focused upon, strengthened and developed key intellectual property in the areas
of Directed Energy applications for our systems and methods. In 2005 and 2006,
we entered into teaming agreements with other defense contractors regarding
cooperative development and marketing of our LIPC and Laser Guided Energy (“LGE”
tm)
technologies and products.
In
2005
and 2006, in response to a heightened threat and at the request of a Government
customer, we developed both major components and demonstrator systems that
can
counter Improvised Explosive Devices (“IEDs”) which constitute a major threat in
several areas of war. During 2005, 2006, and continuing into early 2007 we
completed a series of Government-sponsored tests of these counter-IED systems.
Variations of our counter-IED products include a remotely operated vehicle,
kits
and palletized versions of this direct discharge counter-IED technology.
Technical results of all testing are highly sensitive, but we believe the latest
series of testing is consistent with previous tests and believe that these
tests
accurately reflect the capability of our technology in addressing this critical
mission. We are actively working with the Marine Corps and other Government
organizations to field this technology.
Our
progress in developing our LGE technology has resulted in follow-on contracts,
including recently announced sole-source development activities. In particular,
the Department of Defense (“DoD”) has identified certain urgent counter-IED
applications for directed energy which, we believe, will lead to the development
and fielding of mission-specific LGE platforms in the foreseeable future.
Current year contracted LGE development activities include vehicle stopping
and
counter Vehicle Borne IED (VBIED) missions, which we expect will lead to
follow-on missions for the LGE platform. As these counter-IED initiatives
continue to be advanced by our customer we will be seeking manufacturing
opportunities to field the proximity-related direct discharge products, the
laser-guided versions of these direct discharge products, as well as other
related proprietary technologies.
BASIS
OF PRESENTATION
The
consolidated financial statements include the accounts of Ionatron and our
wholly owned subsidiaries, Ionatron Technologies, Inc. and North Star as of
March 31, 2007 (collectively, "Company," "Ionatron," "we," "our" and "us").
All
intercompany balances and transactions have been eliminated. In the opinion
of
management, all adjustments (which include normal recurring adjustments)
necessary for a fair presentation of the results for the interim periods
presented have been made. The results for the three-month period ended March
31,
2007, may not be indicative of the results for the entire year. The interim
unaudited condensed consolidated financial statements should be read in
conjunction with the Company's audited consolidated financial statements
contained in our Annual Report on Form 10-K.
USE
OF ESTIMATES
The
preparation of consolidated financial statements in conformity with United
States generally accepted accounting principles, which requires management
to
make estimates, judgments and assumptions that affect the amounts reported
in
the financial statements and accompanying notes. Management bases its
assumptions on historical experiences and on various other assumptions that
it
believes to be reasonable under the circumstances, the results of which form
the
basis for making judgments about the carrying values of assets and liabilities
that are not readily apparent from other sources. In addition, Management
considers the basis and methodology used in developing and selecting these
estimates, the trends in and amounts of these estimates, specific matters
affecting the amount of and changes in these estimates, and any other relevant
matters related to these estimates, including significant issues concerning
accounting principles and financial statement presentation. Such estimates
and
assumptions could change in the future as more information becomes known which
could impact the amounts reported and disclosed herein. Significant estimates
include revenue recognition under the percentage of completion method of
contract accounting, the valuation of inventory and stock-based compensation
expense.
-6-
2. ACCOUNTS
RECEIVABLE
Accounts
receivable consist of the following as of March 31, 2007 and December 31,
2006:
March
31, 2007
|
December
31, 2006
|
||||||
Contracts
in progress
|
$
|
560,633
|
$
|
224,080
|
|||
Completed
contracts
|
569,908
|
278,163
|
|||||
Retained
|
100,000
|
100,000
|
|||||
Cost
and estimated earnings on uncompleted contracts
|
569,508
|
44,116
|
|||||
Pre-contract
costs on anticipated contracts
|
709,120
|
618,281
|
|||||
2,509,169
|
1,264,640
|
||||||
Less:
|
|||||||
Allowance
for doubtful accounts
|
-
|
6,277
|
|||||
Total
|
$
|
2,509,169
|
$
|
1,258,363
|
Contract
receivables at March 31, 2007 and December 31, 2006 are expected to be collected
within a year. There are no claims or unapproved change orders included in
contract receivables presented. The retained balances represent a contract
reserve for which a customer has been billed. We expect payment of this reserve
pending the completion of a review by the customer of the project costs. The
December 31, 2006 pre-contract costs on anticipated contracts are costs
applicable to a contract that was probable of being awarded. In April 2007,
we
received a contract on material contained in pre-contract costs. The allowance
for doubtful accounts represents an estimate for potentially uncollectible
accounts receivable related to non-governmental customers which is based upon
a
review of the individual accounts outstanding and the Company’s prior history of
uncollectible accounts receivable.
Costs
and
Estimated Earnings on Uncompleted Contracts
March
31, 2007
|
December
31, 2006
|
||||||
Cost
incurred on uncompleted contracts
|
$
|
1,459,217
|
$
|
127,622
|
|||
Estimated
earnings
|
116,464
|
28,902
|
|||||
Total
billable costs and estimated earnings
|
1,575,681
|
156,524
|
|||||
Less:
|
|||||||
Billings
to date
|
1,006,173
|
112,408
|
|||||
Total
|
$
|
569,508
|
$
|
44,116
|
|||
Included
in accompanying balance sheet under the following
captions:
|
|||||||
Unbilled
costs and estimated earnings on uncompleted contracts included
in accounts
receivable
|
|||||||
$
|
569,508
|
$
|
44,116
|
||||
Billings
in excess of costs and estimated earnings on uncompleted
contracts
|
-
|
-
|
|||||
Total
|
$
|
569,508
|
$
|
44,116
|
-7-
3. INVENTORY
Our
inventories consist of the following as of March 31, 2007 and December 31,
2006:
March
31, 2007
|
December
31, 2006
|
||||||
Raw
materials
|
$
|
1,595,159
|
$
|
1,484,005
|
|||
Raw
materials overhead
|
109,109
|
101,506
|
|||||
Raw
materials reserve
|
(217,280
|
)
|
(343,365
|
)
|
|||
Total
raw materials
|
1,486,988
|
1,242,146
|
|||||
Work-in-process
|
2,773,049
|
2,229,101
|
|||||
Work-in-process
reserve
|
(1,311,310
|
)
|
(1,256,776
|
)
|
|||
Total
work-in-process
|
1,461,739
|
972,325
|
|||||
Total
|
$
|
2,948,727
|
$
|
2,214,471
|
The
March
31, 2007 raw materials reserve of $217,280 and the work in process reserve
of
$1,311,310 were comprised of a reserve for loss on projects of $469,852, and
a
lower of cost or market reserve for $1,058,737. The December 31, 2006 raw
materials reserve of $343,365 and the work in process reserve of $1,256,776
were
comprised of a reserve for loss on projects of $415,318 which has been charged
to cost of revenue and a lower of cost or market reserve for $1,184,823 which
has been charged to general and administrative expenses.
4. STOCK-BASED
COMPENSATION
Stock
Options - Employees and Directors
Effective
January 1, 2006, the Company adopted the fair value recognition provisions
of
Statement of Financial Accounting Standards No. 123(R), “Share Based Payment”
(“SFAS No. 123(R)”), using the modified prospective transition method. Under
that transition method, compensation cost recognized in the three months ended
March 31, 2007 and 2006 includes: (a) compensation cost for all share-based
payments granted prior to, but not yet vested as of January 1, 2006, based
on
the grant date fair value estimated in accordance with the original provisions
of SFAS No. 123, and (b) compensation cost for all share-based payments granted
subsequent to January 1, 2006, based on the grant date fair value estimated
in
accordance with the provisions of SFAS No. 123(R). The fair value for each
option was estimated on the date of grant using the Black-Scholes option-pricing
model. There were no stock options exercised during the three months ended
March
31, 2007
The
following table summarizes the stock options outstanding as of March 31, 2007
as
well as activity during the three months then ended:
Shares
|
Weighted
Average Exercise
Price |
||||||
Outstanding
at December 31, 2006
|
5,562,473
|
$
|
6.10
|
||||
Granted
|
287,500
|
$
|
4.25
|
||||
Exercised
|
-
|
||||||
Forfeited
|
(267,750
|
)
|
$
|
7.30
|
|||
Outstanding
at March 31, 2007
|
5,582,223
|
$
|
5.95
|
||||
Exercisable
at March 31, 2007
|
2,433,390
|
$
|
4.95
|
-8-
As
of
March 31, 2007, the weighted average remaining contractual life of options
outstanding and options exercisable was 3.77 and 3.20 years, respectively.
There
was $6.2 million of total unrecognized compensation cost related to unvested
stock option awards as of March 31, 2007. For both the three months ended March
31, 2007 and 2006, stock-based compensation expense totaled $1.1 million. As
of
March 31, 2007, the aggregate intrinsic value of outstanding options was $3.1
million for 1,824,875 outstanding options in-the-money, and the aggregate
intrinsic value for exercisable options was $2.7 million for of 1,329,542
exercisable options in-the-money (the intrinsic value of a stock option is
the
amount by which the market value of a share of the Company’s common stock
exceeds the exercise price of the option).
Stock
Options and Warrants - Non Employees
At
March
31, 2007 and 2006 there were outstanding warrants to purchase 1.6 million and
589,827 shares of common stock, respectively which were issued in connection
with the August 2006 financing or were outstanding at the date of the merger.
Compensation
expense recorded for 100,000 option shares issued to a non-employee for the
three months ended March 31, 2007 and 2006 was approximately $28,000 for each
period, which was charged to operating expenses with an offsetting entry to
pre-paid assets.
5. INCOME
TAXES
We
adopted the provisions of Financial Standards Accounting Board Interpretation
No. 48 Accounting for Uncertainty in Income Taxes (“FIN 48”) an interpretation
of FASB Statement No. 109 (“SFAS 109”) on January 1, 2007. As a result of the
implementation of FIN 48, we recognized no material adjustment in the liability
for unrecognized income tax benefits. At the adoption date of January 1, 2007
and at March 31, 2007, we had no unrecognized tax benefits.
We
recognize interest and penalties related to uncertain tax positions in income
tax expense. As of March 31, 2007, we had no uncertain tax positions and no
related accrued interest and penalties.
For
the
three months ended March 31, 2006, we recorded a provision for income taxes
of
approximately $11,000 due to an increase in deferred tax liabilities as a result
of the tax amortization of our goodwill. We did not record a provision for
taxes
in the first quarter of 2007 because in the fourth quarter of 2006, we reduced
the fair value of goodwill to zero.
6. SIGNIFICANT
CUSTOMERS
The
substantial majority of our customers is either the U.S. Government or
contractors to the U.S. Government and represents approximately 98% and 98%
of
revenues for the three months ended March 31, 2007 and 2006,
respectively.
7. NET
LOSS PER SHARE
Basic
loss per share is computed as net loss attributable to common stockholders
divided by the weighted average number of common shares outstanding for the
period. Diluted loss per share reflects the potential dilution that could occur
from common shares issuable through exercise of stock options and warrants
and
common shares issuable upon the conversion of convertible instruments. The
dilutive effect of options and warrants and our Series A Convertible Preferred
Stock, which were not included in the total of diluted shares because the effect
was antidilutive, was 1,148,653 and 1,860,528 shares for the three months ended
March 31, 2007 and 2006, respectively, computed using the treasury stock
method.
8.
COMMITMENTS
AND CONTINGENCIES
LITIGATION
In
July
2006, two class action complaints were filed by George Wood and Raymond Deedon
against Ionatron and its founders. Each of the class actions was filed in the
United States District Court for the District of Arizona and allege, among
other
things, violations of Section 10(b) of the Securities Exchange Act of 1934
and
Rule 10b-5, claiming that the Company issued false and misleading statements
concerning the development of its counter-IED product. The court consolidated
these cases, and a consolidated amended complaint was served. On February 16,
2007, the Company and the individual defendants filed a motion to dismiss the
consolidated amended complaint for failure to state a cause of action. On March
30, 2007, the plaintiffs filed papers in opposition to the Company’s motion to
dismiss. We are unable to evaluate the likelihood of an unfavorable outcome
in
this matter or estimate the range of potential loss, if any. However, the
Company intends to defend itself vigorously in any legal
proceedings.
-9-
In
September 2006, a derivative action was filed by John T. Johnasen in Arizona
State Court, Pima County, against certain of the Company’s officers and
directors, alleging, among other things, breach of fiduciary duty. The court
has
stayed the derivative action until June 29, 2007 and has directed the parties
to
give notice when the federal district court rules on the Company’s motion to
dismiss the consolidated complaint in the class action described above, and
to
seek leave of the court if they wish to extend the stay.
In
addition, we may from time to time be involved in legal proceedings arising
from
the normal course of business. As of the date of this report, we have not
received notice of any other legal proceedings.
9.
INDUSTRY
SEGMENTS
In
January 2007, we consolidated the North Star operations into Ionatron’s to more
effectively utilize the shared workforce of the two operations. As a result
of
this consolidation, for 2007 we have also collapsed the reporting segments
of
Ionatron and North Star into one segment for financial reporting purposes since
North Star no longer meets the definition of a segment under SFAS 131,
“Disclosures about Segments of an Enterprise and Related
Information”.
-10-
ITEM
2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS
Our
discussion and analysis of the financial condition and results of operations
should be read in conjunction with the unaudited consolidated financial
statements and the related disclosures included elsewhere herein and in
Management’s Discussion and Analysis of Financial Condition and Results of
Operations included as part of our Annual Report on Form 10-K for the year
ended
December 31, 2006.
CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS
Certain
statements in this Quarterly Report on Form 10-Q constitute forward-looking
statements within the meaning of the securities laws. Forward-looking statements
include all statements that do not relate solely to the historical or current
facts, and can be identified by the use of forward looking words such as "may",
"believe", "will", "expect", "expected", "project", "anticipate", "anticipated
estimates", "plans", "strategy", "target", "prospects" or "continue". These
forward looking statements are based on the current plans and expectations
of
our management and are subject to a number of uncertainties and risks that
could
significantly affect our current plans and expectations, as well as future
results of operations and financial condition and may cause our actual results,
performances or achievements to be materially different from any future results,
performances or achievements expressed or implied by such forward-looking
statements. Important factors that could cause our actual results to differ
materially from our expectations are described Item 1A. (Risk Factors) of our
Annual Report on Form 10-K for the year ended December 31, 2006. In making
these
forward-looking statements, we claim the protection of the safe-harbor for
forward-looking statements contained in the Private Securities Reform Act of
1995. Although we believe that the expectations reflected in such
forward-looking statements are reasonable, there can be no assurance that such
expectations will prove to have been correct. We do not assume any obligation
to
update these forward-looking statements to reflect actual results, changes
in
assumptions, or changes in other factors affecting such forward-looking
statements.
OVERVIEW
Ionatron
was formed to develop and market Directed Energy Weapon products and other
products incorporating its proprietary Laser Induced Plasma Channel ("LIPC")
and
related technologies. Our goal is to deliver products that incorporate our
proprietary technologies for sale to Government customers for specific
applications and platforms as well as products for other commercial customers.
Ionatron has entered into several contracts with the Government for products
and
services as well as Cooperative Research and Development Agreements for joint
research on LIPC-based Directed Energy Weapons and Counter-Weapon Systems.
We
expect to offer Government approved versions of our products for other
Government and non-Government security applications in the future. Since our
inception, we have engaged in research and development and business development
activities. Our first Government contract was received in September of 2003.
During 2004 we demonstrated the laser guided man-made lightning Directed Energy
technology in the laboratory, demonstrated the technology effects on a variety
of targets both under Government contract and using internal research and
development funding, delivered a compact laser system specifically designed
to
enable the technology under a Government contract; and commenced a Government
contract for the development of a system on a mobile platform for field
demonstration and testing. In 2005, utilizing contract and internal research
and
development funds, we continued development of laser sources, advanced high
voltage systems, and special-purpose optical systems, expanded target effects
testing under Government contracts, and furthered our understanding of the
underlying physics of our systems and products. From the company’s inception to
date, we have focused upon, strengthened and developed key intellectual property
in the areas of Directed Energy applications for our systems and methods. In
2005 and 2006, we entered into teaming agreements with other defense contractors
regarding cooperative development and marketing of our LIPC and Laser Guided
Energy (“LGE” tm)
technologies and products.
Since
our
inception, we have pursued the development of a range of core intellectual
property objectives using internal investment, and have aggressively pursued
patents on such technology. The objective of this approach has been to establish
a sole source role for us in customer-funded technology and product development
contracts, as well as to establish barriers to competition. We understand that
our patent applications, in tandem with our significant proprietary knowledge,
can be used as justification for sole source contracts in accordance with
Federal Acquisition Regulations, and thereby avoid the necessity of competitive
solicitations. Presently we have four patents issued and 28 patent applications
in-process. Of the 28 pending patent applications, we have received secrecy
orders on 15 and expect to receive secrecy orders on an additional two. The
U.S.
patent office imposes secrecy orders when disclosure of an invention by
publication of a patent would be detrimental to the National Security. These
patents are treated as under review unless and until they are declassified,
at
which time patents may be issued, with enforcement based on the original filing
date. However, two of these secrecy order patent applications have been found
patentable by the patent office. These patents and patent applications relate
to
our core LIPC technology, counter-IED offerings, and other technologies related
to LGE, laser and high voltage applications.
In
2005
and 2006, in response to a heightened threat and at the request of a Government
customer, we developed both major components and demonstrator systems that
can
counter Improvised Explosive Devices (“IEDs”) which constitute a major threat in
several areas of war. During 2005 and 2006 and continuing into early 2007 we
completed a series of Government-sponsored tests of these counter-IED systems.
Variations of our counter-IED products include a remotely operated vehicle,
kits
and palletized versions of this direct discharge counter-IED technology.
Technical results of all testing are highly sensitive, but we believe the latest
series of testing is consistent with previous tests and we are fully satisfied
that these tests accurately reflect the capability of our technology in
addressing this critical mission. We are actively working with the Marine Corps
and other Government organizations to field this technology. We are fully
satisfied with the technical results of these tests.
-11-
Our
progress in development of our LGE technology has resulted in follow-on
contracts, including recently announced sole-source development activities.
In
particular, the Department of Defense (“DoD”) has identified certain urgent
counter-IED applications for directed energy which, we believe, will lead to
the
development and fielding of mission-specific LGE platforms in the foreseeable
future. Current year contracted LGE development activities include vehicle
stopping and counter Vehicle Borne IED (VBIED) missions, which we expect will
lead to follow-on missions for the LGE platform. As these counter-IED
initiatives continue to be advanced by our customer we will be seeking
manufacturing opportunities to field the proximity-related direct discharge
products, the laser-guided versions of these direct discharge products, as
well
as other related proprietary technologies.
Government
support for our LGE and LIPC technologies continues through Congressional
funding in to the U.S. Navy budget, as well as funding that is transferred
to
the Navy from other services. Ionatron was awarded a $9.8 million dollar
contract by the U.S. Navy that was funded by Congress as part of the fiscal
year
2006 DoD appropriations. The delay in awarding this contract involved
transferring Government property from the previous Government organization
that
funded the initial Transportable Demonstrator project, and the contract could
not be awarded until this material transfer was complete. This contract also
contains a portion of the additional approximately $5.1 million in Government
funding that was identified in the fiscal year 2006 DoD Appropriations Bill
to
implement a new program that is designed to involve several organizations within
the DoD in developing a new application for the core LGE and LIPC technologies.
In
March
2007, the U.S. Army issued a Request-for-Information regarding Laser Guided
Energy capabilities. This request was part of the customer process to validate
that Ionatron has a unique capability so that a sole source contract may be
awarded. It is anticipated that this funding will occur within the next few
months and will be approximately $1.0 million. Previously, the U.S. Army has
provided funding through existing U.S. Navy contracts. The Army has a dedicated
RDT&E (Research Development Testing and Evaluation) funding line for LIPC
technology and is now instituting their own contract vehicle to support this
budgeted program in future years.
The
fiscal year 2007 Defense Authorization bill contained approximately $400,000
of
funding for testing of the counter-IED system technology by the U.S. Marine
Corp. This testing occurred during late January and February 2007. We have
been
informed that the Marine Corp. has forwarded this report to Congress and has
initiated a request for funding for further development of the counter-IED
technology. Initial funding has been identified and approved and, although
there
can be no assurance that a contract will be awarded, a contract to continue
technology development and implementation is expected shortly.
During
the third quarter of 2006, we received a Small Business Technology Transfer
Research Contract from the Army Research Office. This effort involves using
unique aspects of the ultra-short pulse laser technology for remote sensing
applications. We are teamed with the University of Arizona in this effort.
The
first phase of the program was completed successfully and in response to a
request by the Army Research Office, we submitted, an initial Phase II proposal.
The Phase II effort is expected to involve development of a prototype system.
The Army’s schedule for awarding of the Phase II effort is in September 2007,
although there can be no assurance that a contract will be awarded, on a timely
basis, or at all, or the magnitude of such contract.
In
April
2007, we signed an Exclusive Supplier Agreement with a major defense contractor
regarding a non-military application for high voltage electrical systems. This
agreement identifies Ionatron as the preferred supplier for the proprietary
technology being developed. The agreement provides for a close working
relationship between the organizations in developing the technology, and grants
us a license to use the technology, and specific subsystems developed for that
technology, for applications that do not compete with the major contractor’s own
technology initiative.
-12-
RESULTS
OF OPERATIONS
COMPARISON
OF OPERATIONS FOR THE THREE MONTHS ENDED MARCH 31, 2007 AND 2006 IS AS
FOLLOWS:
2007
|
2006
|
||||||
Revenue
|
$
|
2,070,610
|
$
|
5,074,827
|
|||
Cost
of revenue
|
2,337,994
|
4,767,178
|
|||||
General
and administrative
|
2,219,622
|
2,621,496
|
|||||
Selling
and marketing
|
129,800
|
148,958
|
|||||
Research
and development
|
124,023
|
1,075,066
|
|||||
Other
(expense) income:
|
|||||||
Interest
expense
|
(999
|
)
|
(5,243
|
)
|
|||
Interest
income
|
383,826
|
112,120
|
|||||
Other
|
12
|
9
|
|||||
Loss
before provision for income taxes
|
(2,357,990
|
)
|
(3,430,985
|
)
|
|||
Provision
for income taxes
|
-
|
11,299
|
|||||
Net
loss
|
$
|
(2,357,990
|
)
|
$
|
(3,442,284
|
)
|
REVENUE
The
decrease of approximately $3.0 million in revenue for the three months ended
March 31, 2007 compared to 2006 is primarily attributable to the completion
in
2006 of our 12-unit counter IED (“Improvised Explosive Device”) order, while
revenue from our LIPC project increased a modest amount.
COST
OF REVENUE
Cost
of
revenue decreased approximately $2.4 million when compared to the three months
ended March 31, 2006 due to decreased revenue. Cost of revenue includes an
allocation of general and administrative expenses and research and development
costs in accordance with the terms of our contracts. Primarily as a result
of
lower revenue, the amount of allowable general and administrative expenses
allocated to our revenue projects also decreased. The negative gross margin
in
the first quarter of 2007 was primarily due to costs attributed to
non-government based contracts.
GENERAL
AND ADMINISTRATIVE
Reported
general and administrative (“G&A”) expense decreased approximately $402,000
in the first quarter 2007 when compared to the first quarter 2006. G&A
expenses incurred in the first quarter of 2007 compared to the first quarter
2006 actually decreased by approximately $1.8 million. However, fewer G&A
expenses were included in the indirect overhead costs allocated to material
included in the costs of revenue on government contracts during the first
quarter 2006 effectively reducing by $1.4 million the reported difference to
$402,000 when compared to first quarter 2007. The difference in expenses
incurred include the reduction in professional fees of $449,000, provision
for
bad debts and other losses on non-government based contracts of $422,000,
supplies of $277,000, travel of $218,000, temporary help and consultants of
$170,000, and fringe and benefits cost of $154,000.
SELLING
AND MARKETING
Selling
and marketing expenses of approximately $130,000 for the quarter ended March
31,
2007 are a decrease of approximately $19,000 from the $149,000 recognized in
the
quarter ended March 31, 2006, which is reflective of decreased marketing
materials.
RESEARCH
AND DEVELOPMENT
Research
and development (“R&D”) expenses decreased approximately $951,000 during the
three months ended March 31, 2007 as compared to 2006 primarily due to the
approximately $623,000 reduction of allocated labor and overhead on R&D
projects. In the first quarter of 2007, we were focused more on in-process
projects rather than internally funded R&D.
-13-
INTEREST
INCOME AND INTEREST EXPENSE
Net
interest income in the first quarter of 2007 increased approximately $276,000
from the same period of 2006 primarily as a result of additional funds being
provided by the August 2006 financing invested in money market accounts.
NET
LOSS
Our
operations for the three months ended March 31, 2007 resulted in a net loss
of
approximately $2.4 million, a decrease in our period loss of approximately
$1.1
million when compared to the same period in 2006. This decrease is reflective
of
reductions in R&D of approximately $951,000, general and administrative of
$402,000 and an increase of our interest income of $272,000, offset by negative
gross margins attributed to non-government based contracts.
LIQUIDITY
AND CAPITAL RESOURCES
Our
cash
position decreased during the first three months of 2007 by approximately $3.2
million primarily as a result of $3.1 million used in operating activities.
At
March 31, 2007, we had approximately $27.5 million of cash, cash equivalents
and
securities available-for-sale.
During
the first three months of 2007, we used approximately $3.1 million of cash
in
operating activities. This amount is comprised primarily of our net loss of
approximately $2.4 million and increases in accounts receivable of $1.3 million,
inventory of $982,000 and a decrease of accrued expenses, deposits and deferred
rent of $509,000 reduced by non-cash stock option compensation expense of
approximately $1.1 million, depreciation and amortization expense of $271,000,
provision for loss on projects of $248,000 and a reduction of accounts payable
of $224,000. In the first quarter of 2007, investment activities used
approximately $23,000 from the acquisition and disposal of equipment while
financing activities used approximately $44,000 from the early settlement of
two
capital lease obligations.
In
the
course of normal business operations and support for future revenue activities,
we customarily incur approximately $500,000 of future purchase commitments
which
typically settle within 12 months of incurrence.
We
anticipate that short-term and long-term funding needs will be provided from
cash and cash equivalents and available-for-sale marketable securities and
cash
flow from government contracts. We believe that we have sufficient working
capital to fulfill existing contracts and expected contracts in 2007 and into
2008. The transportable demonstrator contract and at least two of the other
Ionatron contracts, that presently represent a major portion of our current
activity, are on a cost plus fixed fee basis. This means all work performed
is
done at our Government-approved rates, which include general and administrative
costs, overhead, labor and materials, fees and profit. These costs are accrued
as incurred and billed monthly. Other contracts are at fixed prices which have
commercial type gross margins associated with them.
BACK-LOG
OF ORDERS
At
March
31, 2007, we had a backlog (that is, work load remaining on signed contracts)
of
approximately $2.6 million to be completed within the next twelve months. The
backlog does not include proposals and contracts under negotiation.
ITEM
4. CONTROLS AND PROCEDURES
EVALUATION
OF DISCLOSURE CONTROLS AND PROCEDURES
Our
management, with the participation of our Chief Executive Officer and Chief
Financial Officer, evaluated the effectiveness of our disclosure controls and
procedures as of March 31, 2007. Based on that evaluation, our Chief Executive
Officer and Chief Financial Officer have concluded that our disclosure controls
and procedures are effective to ensure that information required to be disclosed
by us in reports that we file or submit under the Securities Exchange Act of
1934 is recorded, processed, summarized and reported within the time periods
specified in Securities and Exchange Commission rules and forms. During the
quarter ended March 31, 2007, there was no significant change in our internal
controls over financial reporting that has materially affected, or which is
reasonably likely to materially affect our internal controls over financial
reporting.
-14-
PART
II - OTHER INFORMATION
ITEM
1 LEGAL
PROCEEDINGS
In
July
2006, two class action complaints were filed by George Wood and Raymond Deedon
against Ionatron and its founders. Each of the class actions was filed in the
United States District Court for the District of Arizona and allege, among
other
things, violations of Section 10(b) of the Securities Exchange Act of 1934
and
Rule 10b-5, claiming that the Company issued false and misleading statements
concerning the development of its counter-IED product. The court consolidated
these cases, and a consolidated amended complaint was served. On February 16,
2007, the Company and the individual defendants filed a motion to dismiss the
consolidated amended complaint for failure to state a cause of action. On March
30, 2007, the plaintiffs filed papers in opposition to the Company’s motion to
dismiss. We are unable to evaluate the likelihood of an unfavorable outcome
in
this matter or estimate the range of potential loss, if any. However, the
Company intends to defend itself vigorously in any legal
proceedings.
In
September 2006, a derivative action was filed by John T. Johnasen in Arizona
State Court, Pima County, against certain of the Company’s officers and
directors, alleging, among other things, breach of fiduciary duty. The court
has
stayed the derivative action until June 29, 2007 and has directed the parties
to
give notice when the federal district court rules on the Company’s motion to
dismiss the consolidated complaint in the class action described above, and
to
seek leave of the court if they wish to extend the stay.
In
addition, we may from time to time be involved in legal proceedings arising
from
the normal course of business. As of the date of this report, we have not
received notice of any other legal proceedings.
-15-
ITEM
6 EXHIBITS
EXHIBIT
NUMBER
|
DESCRIPTION
|
|
31.1
|
Certification
of Chief Executive pursuant to Rule 13a-14 or 15d-14 of the Securities
Exchange Act of 1934, as adopted pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|
31.2
|
Certification
of Chief Financial Officer pursuant to Rule 13a-14 or 15d-14 of the
Securities Exchange Act of 1934, as adopted pursuant to Section 302
of the
Sarbanes-Oxley Act of 2002.
|
|
32.1
|
Chief
Executive Officer Certification pursuant to 18 U.S.C. Section 1350,
as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002.
|
|
32.2
|
Chief
Financial Officer Certification pursuant to 18 U.S.C. Section 1350,
as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002.
|
-16-
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
IONATRON, INC. | ||
|
|
|
By | /s/ Dana A, Marshall | |
Dana
A. Marshall
Chief
Executive Officer and President
|
Date:
May
10, 2007
-17-